Virology, Immunology, Immune system, Virus and Epitope are his primary areas of study. His Virology research includes elements of Antibody, Antigen, Immunogenicity, Molecular biology and Gene. As a member of one scientific family, Jorma Hinkula mostly works in the field of Immunology, focusing on Saliva and, on occasion, Blood plasma, Transcytosis and Peripheral blood mononuclear cell.
He combines subjects such as Adjuvant and Vaccination with his study of Immune system. His Virus study deals with Recombinant DNA intersecting with Peptide. His studies deal with areas such as Neutralization and Monoclonal antibody as well as Epitope.
His primary scientific interests are in Virology, Immunology, Immune system, Virus and Antibody. His work carried out in the field of Virology brings together such families of science as Immunogenicity, Molecular biology, DNA vaccination, Epitope and Monoclonal antibody. His research in Vaccination, Immunization, Antigen, Lentivirus and Adjuvant are components of Immunology.
The Vaccination study combines topics in areas such as Immunity and Murine leukemia virus. His study in Immune system is interdisciplinary in nature, drawing from both Plasmid, Gene and Nasal administration. In his study, Vaccinia is inextricably linked to Heterologous, which falls within the broad field of Virus.
Jorma Hinkula mainly focuses on Virology, Immunology, Immune system, Immunogenicity and DNA vaccination. His research in Virology intersects with topics in Epitope, Specific igg and Antigen. His Immune system study combines topics from a wide range of disciplines, such as Virus and Cell biology.
His research investigates the connection between Virus and topics such as Immunity that intersect with problems in Crimean Congo hemorrhagic fever virus and Influenza A virus. The concepts of his DNA vaccination study are interwoven with issues in Secretion, Reverse transcriptase, Electroporation and Polymerase. His biological study spans a wide range of topics, including Cell culture and In vitro.
Jorma Hinkula mainly investigates Immune system, Virology, DNA vaccination, Immunogenicity and Virus. Immune system is a subfield of Immunology that Jorma Hinkula tackles. His DNA vaccination research is multidisciplinary, incorporating perspectives in Crimean Congo hemorrhagic fever virus, Immunity, Epitope, Lytic cycle and Electroporation.
His Immunogenicity research is multidisciplinary, relying on both HIV vaccine, Reverse transcriptase and Neutralizing antibody. Jorma Hinkula has included themes like Cell nucleus and Transcription in his Virus study. His work deals with themes such as Nuclear export signal, Semliki Forest virus and RNA splicing, which intersect with Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients
Sandra Calarota;Göran Bratt;Siv Nordlund;Jorma Hinkula.
The Lancet (1998)
Mucosal and Plasma IgA from HIV-1-Exposed Uninfected Individuals Inhibit HIV-1 Transcytosis Across Human Epithelial Cells
Claudia Devito;Kristina Broliden;Rupert Kaul;Lennart Svensson.
Journal of Immunology (2000)
Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate.
Claudia Devito;Jorma Hinkula;Rupert Kaul;Lucia Lopalco.
AIDS (2000)
Induction of specific T-cell responses in HIV infection
Ann-Charlotte Leandersson;Göran Bratt;Jorma Hinkula;Gustav Gilljam.
AIDS (1998)
Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects.
Claudia Devito;Jorma Hinkula;Rupert Kaul;Joshua Kimani.
Journal of Acquired Immune Deficiency Syndromes (2002)
Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals.
Antonio Cosma;Rashmi Nagaraj;Silja Bühler;Jorma Hinkula.
Vaccine (2003)
Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA immunization followed by highly active antiretroviral treatment.
Sandra A. Calarota;Ann Charlotte Leandersson;Göran Bratt;Jorma Hinkula.
Journal of Immunology (1999)
Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers.
Kristina Broliden;Jorma Hinkula;Claudia Devito;Peter Kiama.
Immunology Letters (2001)
Activation of Innate Immunity, Inflammation, and Potentiation of DNA Vaccination through Mammalian Expression of the TLR5 Agonist Flagellin
Steven E. Applequist;Erik Rollman;Mark D. Wareing;Martin Lidén.
Journal of Immunology (2005)
Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the α-helix of gp41
Mario Clerici;Claudia Barassi;Claudia Devito;Claudia Pastori.
AIDS (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Karolinska Institute
Karolinska Institute
Linköping University
Uppsala University
Yokohama City University
Lund University
Linköping University
Karolinska Institute
University of Milan
University of Manitoba
Beijing Institute of Technology
Tsinghua University
Universiti Malaysia Pahang
University of Bayreuth
Queen's University
The University of Texas at Austin
Hong Kong Polytechnic University
University of Cambridge
University of Exeter
University of California, Irvine
Rockefeller University
Yale University
Imperial College London
Garrahan Hospital
University of York
Stanford University